Development of novel drug delivery systems for targeted cancer therapy.

Thesis Abstract

Abstract
Cancer continues to be a major global health concern, with conventional treatments often lacking specificity and causing significant side effects. The development of novel drug delivery systems for targeted cancer therapy has emerged as a promising approach to improve treatment outcomes. This thesis focuses on exploring innovative drug delivery strategies to enhance the efficacy and selectivity of anticancer agents. The research investigates the design, formulation, and evaluation of various drug delivery systems, including nanoparticles, liposomes, and hydrogels, for targeted delivery of anticancer drugs to tumor sites. Chapter One provides an introduction to the research area, outlining the background of the study, problem statement, objectives, limitations, scope, significance, and structure of the thesis. The chapter also defines key terms relevant to the study, setting the foundation for the subsequent chapters. Chapter Two presents a comprehensive literature review covering ten key aspects related to drug delivery systems for cancer therapy. The review discusses the current challenges in cancer treatment, the need for targeted drug delivery, and the various types of drug carriers available. It also examines recent advances in the field, highlighting emerging technologies and promising approaches for improving the efficacy and safety of anticancer treatments. Chapter Three details the research methodology employed in this study, including the experimental design, materials, and methods used for the formulation and characterization of drug delivery systems. The chapter also discusses the in vitro and in vivo evaluation techniques employed to assess the performance and targeting efficiency of the developed drug carriers. Chapter Four presents a detailed discussion of the findings obtained from the research. The chapter highlights the key outcomes, including the physicochemical properties, drug release profiles, and targeting capabilities of the developed drug delivery systems. The discussion also explores the implications of the results in the context of improving cancer therapy through targeted drug delivery. Chapter Five concludes the thesis by summarizing the key findings and contributions of the research. The chapter discusses the implications of the study results for the field of cancer therapy and outlines future directions for research and development in the area of targeted drug delivery systems for cancer treatment. Overall, this thesis contributes to the growing body of knowledge on novel drug delivery systems for targeted cancer therapy. The research findings provide valuable insights into the design and optimization of drug carriers for improved anticancer drug delivery, with the potential to enhance treatment outcomes and minimize side effects in cancer patients.